| Hiscox Ltd (BMG4593F1389) | |||
12,56 GBXStand (close): 03.07.25 |
 |
||
Nachrichten |
||
| Datum / Uhrzeit | Titel | Bewertung |
| 28.03.25 10:50:38 | Investors in Hiscox (LON:HSX) have seen favorable returns of 52% over the past five years |  |
| When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd like to see the share price move up more than the market average. Unfortunately for shareholders, while the Hiscox Ltd (LON:HSX) share price is up 39% in the last five years, that's less than the market return. Unfortunately the share price is down 3.4% in the last year. So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. Over half a decade, Hiscox managed to grow its earnings per share at 61% a year. The EPS growth is more impressive than the yearly share price gain of 7% over the same period. So it seems the market isn't so enthusiastic about the stock these days. This cautious sentiment is reflected in its (fairly low) P/E ratio of 8.39. You can see how EPS has changed over time in the image below (click on the chart to see the exact values).LSE:HSX Earnings Per Share Growth March 28th 2025 We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. It might be well worthwhile taking a look at our freereport on Hiscox's earnings, revenue and cash flow. What About Dividends? It is important to consider the total shareholder return, as well as the share price return, for any given stock. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. As it happens, Hiscox's TSR for the last 5 years was 52%, which exceeds the share price return mentioned earlier. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 10% in the last year, Hiscox shareholders lost 1.0% (even including dividends). However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 9% per year over half a decade. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Hiscox better, we need to consider many other factors. Take risks, for example - Hiscox has 2 warning signs (and 1 which is a bit concerning) we think you should know about. Story Continues Hiscox is not the only stock insiders are buying. So take a peek at this freelist of small cap companies at attractive valuations which insiders have been buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments |
||
| 14.03.25 16:08:00 | Sapiens Cloud Adopted by Hiscox UK: Should You Watch the Stock? | |
| Sapiens International SPNS announced that Hiscox UK went live with the Sapiens Insurance Platform on Sapiens Cloud. This migration from Microsoft's MSFT cloud platform Azure to SPNS’s cloud-native architecture, powered by Kubernetes, resulted in a 30% improvement in application speed. The transition enhances operational efficiency and service consistency, aligning with Hiscox UK’s long-term strategy of digital transformation and customer-centric innovation. The Sapiens Insurance Platform is an AI-driven, open and integrated solution that accelerates adoption and maximizes long-term value. It enables insurers to scale, modernize and optimize operations efficiently. The move also enables Hiscox UK to leverage Sapiens's modern API layer, facilitating seamless integration with top-tier solutions for rating, rules and document management alongside extended digital trading capabilities. This ecosystem empowers Hiscox UK to deliver agile services across its market-leading offerings for both commercial lines and high-net-worth private clients. Can Sapiens Cloud’s Deal With Hiscox UK Boost Its Stock? Hiscox UK's transition to the Sapiens Insurance Platform on Sapiens Cloud could positively impact the SPNS stock’s performance. The successful deployment enhances Sapiens' credibility in the insurance technology space, attracting more clients and driving revenue growth. Sapiens' successful cloud migration for Hiscox UK, delivering a 30% boost in application speed, underscores the strength of its cloud-native architecture. This proven efficiency could position SPNS as a top choice for insurers seeking modernization. The ongoing collaboration with Hiscox UK, a partner since 2014, exemplifies Sapiens' commitment to delivering tangible business benefits, fostering a strong foundation for sustainable growth and continuous innovation. However, Sapiens faces competition from Synchronoss Technologies SNCR and Verint Systems VRNT, both of which offer advanced technology solutions to enterprises. While Synchronoss excels in cloud and digital transformation for telecom providers, Verint focuses on AI-powered customer engagement and workforce optimization, posing challenges to Sapiens' market presence. SPNS’s Revenues Hit by Unfavorable Forex Sapiens faced significant headwinds due to unfavorable forex, which negatively impacted its revenue growth. As a global company operating in multiple regions, SPNS generates a substantial portion of revenues in foreign currencies, including the euro, British pound and Israeli shekel. In the fourth quarter of 2024, the depreciation of key currencies relative to the U.S. dollar resulted in a revenue drag, affecting the company's top-line growth despite stable business operations. Story Continues Sapiens’ Earnings Estimates Trend Downward The Zacks Consensus Estimate for SPNS’s first-quarter 2025 earnings is pegged at 35 cents, which has moved down by a penny over the past 30 days. The estimate indicates a 2.78% year-over-year decline. The Zacks Consensus Estimate for SPNS’s 2025 earnings has declined by 3 cents to $1.46 per share in the past 30 days. The estimate indicates a 1.35% decline from the 2024 actual. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Microsoft Corporation (MSFT) : Free Stock Analysis Report Synchronoss Technologies, Inc. (SNCR) : Free Stock Analysis Report Verint Systems Inc. (VRNT) : Free Stock Analysis Report Sapiens International Corporation N.V. (SPNS) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments |
||
| 12.03.25 11:50:00 | Hiscox UK Goes Live with Sapiens Insurance Platform on Sapiens Cloud | |
| The go-live powers Hiscox with operational excellence and business growth UXBRIDGE, England, March 12, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that Hiscox, a leading insurer of tailored solutions for both businesses and high-net-worth private clients, has gone live with Sapiens Insurance Platform, now fully deployed on the Sapiens Cloud. The strategic go-live underscores Hiscox's commitment to enhancing business performance, resilience, and customer satisfaction.Sapiens Logo A Sapiens' partner since 2014, Hiscox UK embarked on the strategic migration of Sapiens Insurance Platform from their Microsoft Azure installation and operation to the Sapiens Cloud. The move marks a pivotal alignment with their long-term business objectives, enabling a significant boost in application efficiency and technological agility. By migrating to Sapiens' latest cloud-native architecture, powered by Kubernetes, Hiscox UK immediately realised an average 30% improvement in application speed. This has translated into improved operational productivity, and more consistent service delivery. Benefiting from Sapiens' R&D investments, Hiscox can now leverage a modern API layer, providing improved integration opportunities with best-of-breed solutions for rating, rules, and document management, plus extended digital trading capabilities. This ecosystem allows Hiscox to deliver enhanced, agile services across market-leading offerings for commercial lines and private clients with significant assets. "Sapiens Insurance Platform is pivotal to Hiscox's continued growth, enabling us to create a connected ecosystem with the best technologies available to help deliver our strategic goals" said Ian Wrigglesworth, Hiscox CTO. "By wrapping two years of new features into a single update, the Sapiens' go-live has helped strengthen the operational foundations of our business, which is fundamental to our strategy for growth." "Our long-term partnership with Hiscox exemplifies Sapiens' commitment to delivering tangible business benefits through a high-performance, resilient platform," said Roni Al-Dor, Sapiens President and CEO. "By migrating to the Sapiens Cloud with Sapiens Insurance Platform, we not only empower Hiscox with cutting-edge technology but also provide a robust foundation for continuous innovation and sustainable growth." Sapiens Insurance Platform is an AI-based, open, integrated platform that accelerates adoption, delivers sustained value, and empowers insurers to grow, modernise and optimise. Story Continues About The Hiscox Group Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE: HSX). Our ambition is to be a respected specialist insurer with a diverse portfolio by product and geography. We believe that building balance between catastrophe-exposed business and less volatile local specialty business gives us opportunities for profitable growth throughout the insurance cycle. The Hiscox Group employs over 3,000 people in 13 countries, and has customers worldwide. Through the retail businesses in the UK, Europe, Asia and the USA, we offer a range of specialist insurance products in commercial and personal lines. Internationally traded, bigger ticket business and reinsurance is underwritten through Hiscox London Market and Hiscox Re & ILS. Our values define our business, with a focus on people, courage, ownership and integrity. We pride ourselves on being true to our word and our award-winning claims service is testament to that. For more information, visit www.hiscoxgroup.com. About Sapiens Sapiens International Corporation (NASDAQ: SPNS) (TASE: SPNS) is a global leader in intelligent insurance software solutions. With Sapiens' robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. We help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers' compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative SaaS offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success. For more information visit https://sapiens.com or follow us on LinkedIn. Investor and Media Contact Yaffa Cohen-Ifrah Sapiens Chief Marketing Officer and Head of Investor Relations Email: Yaffa.cohen-ifrah@sapiens.com Forward Looking Statements Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; the global macroeconomic environment, including headwinds caused by inflation, relatively high interest rates, potentially unfavorable currency exchange rate movements, and uncertain economic conditions, and their impact on our revenues, profitability and cash flows; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the coronavirus epidemic, and fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2023, to be filed in the near future, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations. Logo - http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpgCision View original content:https://www.prnewswire.co.uk/news-releases/hiscox-uk-goes-live-with-sapiens-insurance-platform-on-sapiens-cloud-302399797.html View Comments |
||
| 01.03.25 09:54:03 | Hiscox Full Year 2024 Earnings: EPS Beats Expectations |  |
| Hiscox (LON:HSX) Full Year 2024 Results Key Financial Results Revenue: US$4.03b (up 9.0% from FY 2023). Net income: US$627.2m (down 12% from FY 2023). Profit margin: 16% (down from 19% in FY 2023). The decrease in margin was driven by higher expenses. EPS: US$1.83 (down from US$2.06 in FY 2023).LSE:HSX Earnings and Revenue Growth March 1st 2025 All figures shown in the chart above are for the trailing 12 month (TTM) period Hiscox EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 8.6%. Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 7.6% growth forecast for the Insurance industry in the United Kingdom. Performance of the British Insurance industry. The company's shares are up 14% from a week ago. Risk Analysis Before we wrap up, we've discovered 2 warning signs for Hiscox (1 shouldn't be ignored!) that you should be aware of. Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments |
||
| 28.02.25 07:06:28 | Hiscox Ltd (HCXLF) Full Year 2024 Earnings Call Highlights: Record Profits and Strategic Growth ... | |
| Revenue Increase: $170 million increase in revenue, with $150 million from the retail business. Undiscounted Combined Ratio: 93.6% for retail and 81.6% for big ticket. Retail Profits: Approximately $300 million. Record Profits: $685 million for the group. Return on Equity: 19.8%. Final Dividend Increase: 20% increase, leading to a full-year EPS increase of 15%. Special Return of Capital: $175 million through a share buyback. Insurance Contract Written Premium (ICWP): Increased by $169 million. Expense Ratio Improvement: Decreased by around 1 percentage point. Investment Return: $384 million. Net Loss from California Wildfires: Estimated at $170 million. Net Premium Growth in Re & ILS: Over 11% increase. Fee Income from ILS Strategies: Record $128 million. Retail ICWP Growth: 5.1% in constant currency to $2.5 billion. London Market ICWP Decline: 2% decline. Net ICWP Growth in Re & ILS: 11.1% increase. Investment Return Rate: 4.8%. Reserve Releases: $146 million or 3.7% of opening reserves. Net Asset Value (NAV) per Share Growth: 14% year-on-year. Estimated BSCR: 225%. Warning! GuruFocus has detected 2 Warning Sign with HCXLF. Release Date: February 27, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Hiscox Ltd (HCXLF) reported record profits of $685 million for the second consecutive year, with a strong return on equity of 19.8%. The company achieved broad-based growth, increasing revenues by approximately $170 million, primarily driven by its retail business. Hiscox Ltd (HCXLF) announced a 20% increase in its final dividend, reflecting a full-year EPS increase of 15%, and a special return of capital of $175 million through a share buyback. The retail segment showed strong growth, with the UK business growing at its fastest rate since 2018, and the European business delivering robust growth with new distribution partnerships. The Re & ILS segment delivered a combined ratio of 69% and attracted $460 million of new inflows into ILS strategies, contributing to record fee income of $128 million. Negative Points The US broker business contracted in 2024, although there is an expectation of returning to growth in 2025. The London market business saw a decline in ICWP by 2% due to proactive cycle management and exiting certain business lines like space. The California wildfires in Q1 2025 resulted in an estimated net loss of $170 million, impacting the Re & ILS segment significantly. The Bermuda corporate income tax implementation will increase the group's effective tax rate to between 15% and 20%, with uncertainty around the future benefit of a $155 million deferred tax asset. The group faced a challenging environment with over 200 large risk losses notified in 2024, an 8% increase year-on-year, highlighting the active loss year. Story Continues Q & A Highlights Q: Can you provide more color on the confidence behind the 6% growth target for retail, especially with some segments accelerating into double digits? A: Hamayou Akbar Hussain, CEO: The 6% growth target is based on a gradual increase from 4% in 2023 to 5% in 2024, with expectations for continued momentum in 2025. This growth is driven by management actions such as brand reinvigoration, distribution capability enhancements, and efficiency improvements. The new business policy count doubled in 2024 compared to 2023, indicating strong underlying improvement. Q: How do you view the impact of the California wildfires on your capital return decisions? A: Hamayou Akbar Hussain, CEO: The wildfires did not significantly impact our capital return decisions. Our balance sheet remains robust, and we continue to follow our capital framework, which prioritizes growth, balance sheet strength, and returning excess capital to shareholders. Q: Can you elaborate on the sustainability of the $128 million fee income and its components? A: Paul Cooper, CFO: The $128 million fee income is entirely from Re & ILS, with a significant portion being volume-driven. We attracted $460 million of additional capital and grew our quota share outwards. While profit commissions have been substantial due to low combined ratios, the expectation for 2025 is that the profit commission element will be lower. Q: What is your outlook for growth in the London market, especially given the current rate environment? A: Joanne Musselle, Chief Underwriting Officer: We see good opportunities to grow in the London market, particularly in areas like ESG syndicates and renewable construction projects. While we exercise discipline in areas like casualty where rates have softened, we believe the majority of our portfolio is priced to deliver attractive returns. Q: How do you plan to use the excess capital, given the current BSCR level? A: Paul Cooper, CFO: We retain capital for growth and balance sheet strength, with any excess considered for shareholder returns. We maintain financial flexibility to capitalize on emerging opportunities, and our capital management framework ensures we are good custodians of shareholder capital. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments |
||
| 28.02.25 06:19:54 | Is Hiscox Ltd's (LON:HSX) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? | |
| Most readers would already be aware that Hiscox's (LON:HSX) stock increased significantly by 13% over the past week. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study Hiscox's ROE in this article. Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Simply put, it is used to assess the profitability of a company in relation to its equity capital. Check out our latest analysis for Hiscox How Do You Calculate Return On Equity? Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Hiscox is: 17% = US$627m ÷ US$3.7b (Based on the trailing twelve months to December 2024). The 'return' refers to a company's earnings over the last year. That means that for every £1 worth of shareholders' equity, the company generated £0.17 in profit. What Is The Relationship Between ROE And Earnings Growth? Thus far, we have learned that ROE measures how efficiently a company is generating its profits. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features. Hiscox's Earnings Growth And 17% ROE At first glance, Hiscox seems to have a decent ROE. Further, the company's ROE compares quite favorably to the industry average of 13%. This certainly adds some context to Hiscox's exceptional 63% net income growth seen over the past five years. However, there could also be other causes behind this growth. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio. When you consider the fact that the industry earnings have shrunk at a rate of 21% in the same 5-year period, the company's net income growth is pretty remarkable.LSE:HSX Past Earnings Growth February 28th 2025 Earnings growth is a huge factor in stock valuation. It’s important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). Doing so will help them establish if the stock's future looks promising or ominous. If you're wondering about Hiscox's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry. Story Continues Is Hiscox Making Efficient Use Of Its Profits? The three-year median payout ratio for Hiscox is 31%, which is moderately low. The company is retaining the remaining 69%. By the looks of it, the dividend is well covered and Hiscox is reinvesting its profits efficiently as evidenced by its exceptional growth which we discussed above. Additionally, Hiscox has paid dividends over a period of at least ten years which means that the company is pretty serious about sharing its profits with shareholders. Our latest analyst data shows that the future payout ratio of the company is expected to drop to 22% over the next three years. Regardless, the future ROE for Hiscox is predicted to decline to 13% despite the anticipated decrease in the payout ratio. We reckon that there could probably be other factors that could be driving the forseen decline in the company's ROE. Summary On the whole, we feel that Hiscox's performance has been quite good. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company. Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments |
||
| 27.02.25 08:01:53 | Hiscox takes £134m hit on LA wildfires after second year of record profit | |
| Hiscox (HSX.L) has said it will take a 170 million dollar (£134 million) hit from the Los Angeles wildfires which broke out at the start of 2025. The wildfires, which raged during the first half of January, have been estimated by some to be the costliest natural disaster in US history. More than 16,200 structures were destroyed as flames ripped through Pacific Palisades, Malibu, Pasadena and Altadena areas of Los Angeles. Hiscox said on Thursday that the wider insurance industry loss could be as high as 40 billion dollars (£31.6 billion), while most of its own losses would come through its reinsurance arm, Hiscox RE & ILS. Estimates of the total economic loss from the firestorm have been estimated to surpass 250 billion dollars (£197.9 billion). And property losses from the Palisades and Eaton fires alone have been predicted to potentially top 30 billion dollars (£23 billion), according to a Los Angeles Times analysis. Hiscox, meanwhile, said it would book its own loss on the event in the first quarter of the upcoming financial year, as it revealed a second consecutive year of record profit. The insurer made 685.4 million dollars (£541 million) in pre-tax profit in 2024, up nearly a 10th year-on-year. The group said the wildfires caused “tragic loss of life and widespread destruction. We extend our sympathies to our customers and to all of those impacted by these events”. Hiscox also pointed to a 28 million dollar (£22 million) loss from the Baltimore Bridge collapse, which saw the major US suspension bridge collapse after a container ship struck one of its piers. The group said 2024 was also an “active natural catastrophe year”, pointing to five hurricanes in the US, flooding in Spain, Germany and central Europe and more extreme weather events in Canada. It said natural catastrophe-related losses were “within expectations”, while Hurricane Milton, which struck Florida in October did not result in as big a loss as expected. It added: “Hiscox exists to support our customers at times like this and we firmly believe that a high-quality claims service is essential to help them get back on their feet as quickly as possible.” View Comments |
||
| 19.02.25 12:00:00 | Mile Marker Launches With New Business Momentum With Growth-Oriented Brands | |
| The new "tell-it-like-it-is" independent media agency, spawned from the merger of Cage Point and PlusMedia, has secured AOR assignments from Bridges Consumer Healthcare LLC, Carlin Consumer Health, and business insurance brand Hiscox USA. NEW YORK, Feb. 19, 2025 /PRNewswire/ -- Mile Marker, the new-breed independent media agency tailored specifically for the ambitions of today's growth marketers, is proud to announce three new agency-of-record partnerships with Bridges Consumer Healthcare LLC, Carlin Consumer Health, and business insurance brand Hiscox USA.(PRNewsfoto/PlusMedia) "All 3 of these marketers hit the bullseye of what Mile Marker seeks in client partnerships," said Shattuck Groome, Mile Marker, Chief Media Officer. "They each demand honesty, transparency and an analytics-driven approach to delivering business outcomes for their brands from their agency partners. They expect deep, best-in-class expertise across the consumer journey and its influence on all media channels. This aligns seamlessly with our agency values." "We are on an aggressive growth trajectory and we needed to find a media agency partner that is attuned to our mandate for quick growth and possesses the chops to fulfill it," said John Speranza, CEO at Bridges Consumer Healthcare. "Of all the agencies that came forward, Mile Marker stood out for its proven track record in shaping their clients' multichannel mix to optimize ROAS and deliver on business outcomes with a sophisticated, transparent approach to analytics and applying emerging growth channels like retail media." All 3 accounts were awarded to Mile Marker after comprehensive agency reviews. For Bridges and Carlin, Mile Marker is tasked with driving both awareness and retail sales for a range of brands within their portfolios with an omnichannel approach. The brief for Hiscox USA will be to drive greater upper-funnel brand awareness and consideration within its key B2B audience segments. With an integrated set up built around a fierce commitment to elevating media performance beyond KPIs, Mile Marker will operate with full integration and technical customization to bring together brand and performance media and deliver what really matters to clients - scalable growth. Mile Marker is the newly constituted shop from the merger of PlusMedia and Cage Point. By blending the strategic precision and analytical insights from both businesses across all channels, Mile Marker represents an end to end media agency that now merges the digital and physical worlds, helping brands connect with their audiences wherever they are. The combined executive leadership team meshes an entrepreneurial and founder mindset with C-level holding company experience to drive an independent media agency with a laser focus on clients on the precipice of explosive growth. Story Continues About Mile Marker Mile Marker is a "tell-it-like-it-is" media agency that blends deep platform expertise with human EQ and analytical IQ. With headquarters in New York City, serving sophisticated marketers in the small-to-medium enterprise space, for whom we manage $500M in comprehensive media. Mile Marker's client roster includes FreshPet, DoorDash, Webster Bank, Harry's, Feeding America among others. For more information go towww.milemarkeragency.com. About Bridges Consumer Healthcare Based in Chattanooga, Tennessee, Bridges' mission is to build a leading consumer healthcare company focused on OTC and personal care products and driven by consumer-led innovation and marketing. For more information, please visit www.bridgeschc.com. About Carlin Consumer Health Founded in 2022 and based in New York City, NY, Carlin is a consumer health business uniquely positioned to acquire leading over-the-counter brands. Carlin was formed by leading sponsors, Hildred Capital Management, Bourne Partners Strategic Capital, and The Emerson Group, and initially acquired a leading acid reducer brand, Zegerid OTC®. For more information, please visit carlinconsumerhealth.com/. About Hiscox Hiscox is a global specialist insurer, headquartered in Bermuda and listed on the London Stock Exchange (LSE:HSX). Hiscox USA provides a variety of admitted or specialty risk solutions, including a broad spectrum of professional liability, general liability, cyber and data security, media liability, management liability, crime, entertainment, and terrorism insurance products. Media Contact: Hank kim, hank@m8media.netCision View original content to download multimedia:https://www.prnewswire.com/news-releases/mile-marker-launches-with-new-business-momentum-with-growth-oriented-brands-302377802.html SOURCE Mile Marker LLC View Comments |
||
| 16.01.25 10:33:08 | Is Now The Time To Put Hiscox (LON:HSX) On Your Watchlist? | |
| For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should. If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, then you may well be interested in Hiscox (LON:HSX). While profit isn't the sole metric that should be considered when investing, it's worth recognising businesses that can consistently produce it. See our latest analysis for Hiscox Hiscox's Improving Profits Hiscox has undergone a massive growth in earnings per share over the last three years. So much so that this three year growth rate wouldn't be a fair assessment of the company's future. Thus, it makes sense to focus on more recent growth rates, instead. To the delight of shareholders, Hiscox's EPS soared from US$1.36 to US$2.12, over the last year. That's a fantastic gain of 56%. Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. It's noted that Hiscox's revenue from operations was lower than its revenue in the last twelve months, so that could distort our analysis of its margins. EBIT margins for Hiscox remained fairly unchanged over the last year, however the company should be pleased to report its revenue growth for the period of 16% to US$3.8b. That's progress. In the chart below, you can see how the company has grown earnings and revenue, over time. Click on the chart to see the exact numbers.LSE:HSX Earnings and Revenue History January 16th 2025 While we live in the present moment, there's little doubt that the future matters most in the investment decision process. So why not check this interactive chart depicting future EPS estimates, for Hiscox? Are Hiscox Insiders Aligned With All Shareholders? It should give investors a sense of security owning shares in a company if insiders also own shares, creating a close alignment their interests. Hiscox followers will find comfort in knowing that insiders have a significant amount of capital that aligns their best interests with the wider shareholder group. As a matter of fact, their holding is valued at US$17m. That's a lot of money, and no small incentive to work hard. While their ownership only accounts for 0.5%, this is still a considerable amount at stake to encourage the business to maintain a strategy that will deliver value to shareholders. Story Continues Is Hiscox Worth Keeping An Eye On? If you believe that share price follows earnings per share you should definitely be delving further into Hiscox's strong EPS growth. This EPS growth rate is something the company should be proud of, and so it's no surprise that insiders are holding on to a considerable chunk of shares. On the balance of its merits, solid EPS growth and company insiders who are aligned with the shareholders would indicate a business that is worthy of further research. You still need to take note of risks, for example - Hiscox has 2 warning signs (and 1 which shouldn't be ignored) we think you should know about. While opting for stocks without growing earnings and absent insider buying can yield results, for investors valuing these key metrics, here is a carefully selected list of companies in GB with promising growth potential and insider confidence. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments |
||
| 15.10.24 07:22:38 | Hiscox Ltd (LON:HSX) is favoured by institutional owners who hold 78% of the company | |
| Key Insights Institutions' substantial holdings in Hiscox implies that they have significant influence over the company's share price 53% of the business is held by the top 8 shareholders Ownership research along with analyst forecasts data help provide a good understanding of opportunities in a stock To get a sense of who is truly in control of Hiscox Ltd (LON:HSX), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 78% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk). Given the vast amount of money and research capacities at their disposal, institutional ownership tends to carry a lot of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. Let's take a closer look to see what the different types of shareholders can tell us about Hiscox. See our latest analysis for Hiscox ownership-breakdown What Does The Institutional Ownership Tell Us About Hiscox? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index. Hiscox already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Hiscox's historic earnings and revenue below, but keep in mind there's always more to the story. earnings-and-revenue-growth Investors should note that institutions actually own more than half the company, so they can collectively wield significant power. We note that hedge funds don't have a meaningful investment in Hiscox. Sun Life Global Investments Inc. is currently the company's largest shareholder with 9.2% of shares outstanding. Capital Research and Management Company is the second largest shareholder owning 8.4% of common stock, and Fidelity International Ltd holds about 7.9% of the company stock. We also observed that the top 8 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent. Story continues While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of Hiscox The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances. Our information suggests that Hiscox Ltd insiders own under 1% of the company. It is a pretty big company, so it would be possible for board members to own a meaningful interest in the company, without owning much of a proportional interest. In this case, they own around UK£18m worth of shares (at current prices). It is good to see board members owning shares, but it might be worth checking if those insiders have been buying. General Public Ownership The general public-- including retail investors -- own 16% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Next Steps: I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Hiscox (at least 1 which is significant) , and understanding them should be part of your investment process. But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View comments |
||
